January 2007 Vol 7 correct A.indd ABSTRACT Objective: To ascertain the relationship between serum leptin levels and related variables (weight, Body Mass Index (BMI) and fat percentage) in a group of Omani obese and non-obese healthy subjects. Methods: Leptin levels were assessed in serum samples from 35 obese Omanis and 20 non-obese healthy subjects. Results: There was a significant difference (p< 0.00) in serum leptin between the obese group (34.78 + 3.96 ng/ml) and the control non-obese subjects (0.6 ± 4.2 ng/ml). Leptin levels were higher in females compared to males. There was a significantly positive correlation between leptin levels in obese subjects with weight (p=0.002), body fat percentage (p=0.000) and BMI (p=0.00). Conclusions: We concluded that serum leptin levels are higher in the Omani obese group and correlate positively with body fatness and obesity. Keywords: Leptin, Obesity, Body weight, Oman, Body Mass Index Correlation between Serum Leptin Levels, Body Mass Index and Obesity in Omanis *Masoud Y Al Maskari1, Adel A Alnaqdy2 SULTAN QABOOS UNIVERSITY MEDICAL JOURNAL DECEMBER 2006 VOL 6, NO. 2 SULTAN QABOOS UNIVERSITY© THE NAME LEPTIN IS DERIVED FROM THE leptose, meaning thin.1,3,5 It is secreted by the adipose tissue in proportion to adipose mass and therefore its circulating levels increase with weight gain and decrease with weight loss.1,2 A large amount of research has been conducted on leptin since its discovery in 1994 and it is now possible to evaluate the physiological significance of leptin.1,2,3,4 Leptin is considered to play a wide range of functions in humans such as decreasing appetite and thereby food intake, stimulating and maintaining energy expenditure and acting as a metabolic hormone in a wide range of proc- esses by binding to receptors in the brain.5 Leptin func- tions primarily as an anti-obesity hormone. Its serum concentrations in healthy individuals positively corre- late with body fat content,3 but it correlates negatively when energy intake is reduced and energy stores in fat are declining.6 In most obese subjects, leptin levels are high and correlate with the Body Mass Index (BMI) and the percentage of body fat,3 Leptin levels are found to be correlated with a number of endocrine substances such as insulin, glucocorticoids, thyroid hormones and testosterone.7 Similar studies also indicate that it may be involved in mediating some endocrine-related proc- esses, like the onset of puberty.8 Impaired or modified receptor functions may be associated with certain med- ical conditions other than obesity, such as cardiovas- 1Department of Medicine, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. 35 Al-Khod 123, Sultanate of Oman 2Department of Microbiology & Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. 35 Al-Khod 123, Sultanate of Oman *To whom correspondence should be addressed. Email: mmaskari@squ.edu.om O R I G I N A L S T U D Y و والسمنة كتلة الوزن، ومؤشر الليبيتني هرمون مستويات بني الترابط البدينني مانيني العُ عند اجلسم في الدهون نسبة ــبة ونس ــم اجلس كتلة معامل (الوزن، العالقة ذات املتغيرات بعض مع الدم الليبيتني في هرمون ــتويات بني مس من العالقة امللخص: الهدف: التحقق 35 عمانيا دم عيناتِ في الليبيتني هرمون ــتويات مس فحص الطريقة: مت غير البدينني. من البدينني وأخرى العمانيني من موعة ــم) الدهون في اجلس ng/± 34.78) البدينة ــة اموع بني (p<0.001) الليبتني هرمون ــتوى تَدّ في مس عْ مُ إحصائي فرق ــر النتائج: ظه . بدينَ ــرَ غي ــا 20 عماني و ِ ــا ، بدين الذكورِ في ــه من اإلناثِ في أعلىَ ــت كان الليبيتني هرمون ــتويات مس ــد أن وج . (4.2±ng/ml10.6 ) ــة البدين ــر غي ــة الضابط ــة ml13.96 ) واموع في الدهون ــبة ، نس (p=0.002) ــمِ اجلس وزنِ مع البدينني الليبيتني في ــتويات هرمون مس بني قوي ارتباط إيجابي وجد أيضا أن هناك كما .(p<0.05) اموعةِ في كانت أعلى الدم في الليبيتني هرمون مستويات أن ذلك من اخلالصة: يستنتج .(p=0.001) ومؤشر كتلة اجلسم (p= 0.0001) اجلسم والسمنة. اجلسم الدهون في نسبة الوزن، مع وتقترن إيجابيا البدينةِ بدين ، اجلسم كتلة ، مؤشر ، السمنة مان عُ املفردات املفتاحية: هرمون الليبيتني، M A S O U D Y A L - M A S K A R I A N D A D E L A A L N A Q D Y 28 cular disease9 and certain types of cancer.10 Research findings also indicate that leptin can act as a growth factor in the foetus and in the neonate.7 It has been reported that obesity is a major risk factor for the development of diabetes mellitus11, therefore, leptin might play a role in this disease. Many studies have documented a high prevalence of diabetes and metabolic syndrome among the Oma- ni population.12,13,14 No data are available in the lit- erature for levels of serum leptin among the Omani population. Studying leptin levels in Omanis may be relevant in the light of reported associations of leptin serum status with obesity and diabetes. Certain social economic and environmental factors may be unique in the Omani population. The objective of this study was to report leptin profiles in Omanis and to ascertain the relationship between serum leptin levels and related variables (weight, BMI and fat percentage) between two groups of Omanis, obese and non-obese healthy subjects. M E T H O D S This study was approved by the Sultan Qaboos Univer- sity Medical Research and Ethics Committee (Project No. MREC 155). SUB JE C TS A group of 35 Omani subjects, who were attending our obesity clinic (25 female and 10 males, age range 22-49 years) and were considered to be obese on the basis of BMI. BMI was defined as weight in kilogrames divided by height in meters (kg/m2). A BMI value of > or equal to 30 was used as an indicator of obesity. Fat percent- age was measured by a Tanita Fat Analyser (USA) using the Bioelectrical Impedance method. Twenty healthy non-obese subjects of similar age range (20- 50 years) served as a control group. None of the sub- jects studied had any clinical or laboratory (e.g: fasting blood glucose, urea & electrolytes, liver and thyroid function tests) signs of disease associated with obesity and were taking no drugs. SE RUM L E P TI N A S SAY An in vitro sandwich Enzyme-Linked Immunosorb- ent Assay (ELISA) (DRG Instrument GmbH, Germa- ny) was employed for the quantitative measurement of human leptin in serum. The microtiter wells were coated with a monoclonal anti-leptin antibody. Test and control samples were incubated in the coated wells with a specific rabbit anti-leptin antibody. After incubation the unbound material was washed off and anti-rabbit peroxidase conjugate was added for detec- tion of the bound leptin. The intensity of colour devel- oped was proportional to the concentration of leptin Table 1: Comparison between charateristics of obese subjects (25 female: 10 male; mean ± SE) Character Female(n=25) Male(n=10) Age (years) 29.2 ± 1.6 30.0 ± 3.1 Leptin(ng/ml) 38.2 ± 2.5 27.0 ± 4.9 Weight (Kg) 97.9 ± 3.9 108.4 ± 7.6 BMI (kg/m2) 39.6 ± 1.5 39.0 ± 2.9 %Fat 44.1 ± 1.0 38.3 ± 3.9 Figure 1: Leptin levels (mean + SE) in obese (BMI>30kg/m2) and non-obese Omani subjects C O R R E L AT I O N B E T W E E N S E R U M L E P T I N L E V E L S , B O D Y M A S S I N D E X A N D O B E S I T Y I N O M A N I S 29 in the sample. STATI STI C A L A N A LY SI S We used a Statistical Product and Service Solutions (SPSS) software program for statistical analysis of data. A p value of < 0.05 was considered statistically significant. R E S U L T S As seen in Figure 1, there was a significant differ- ence (p=0.001) in serum leptin levels (mean + S.E.) between the obese group (34.78 + 13.96 ng/ml) and levels in the control (non-obese) subjects (10.6 + 4.2 ng/ml). A strongly significant positive correlation was observed between leptin levels with weight (r=0.5, p =0.002), BMI (r= 0.51, p =0.001) and body fat percent- age (r=0.7, p =0.0001) [Figure 2]. Leptin concentrations and body fat percentages were higher in women than in men within the obese group Table 1. A strong positive correlation (r=0.528, p <0.007) was present when leptin concentration and BMI of the female obese group was compared. D I S C U S S I O N In this study, we have described significantly high se- rum leptin levels among obese Omani subjects com- pared to the non-obese group, though the number studied here is small. To our knowledge, this has not been reported previously in the Omani popula- tion. Normal ranges of leptin (in Caucasian and Arab residents of Kuwait),15,26 which have been reported in previous studies, are comparable to the range ob- served in the non-obese group in the current study. In a study carried out by Concidine et al.,3 it was found that obese humans had (on average) leptin levels four times higher than non-obese individuals. The present study confirms results of previous reports16,17 regarding a gender difference in leptin levels between males and females. Females have higher se- rum leptin concentrations than males, which confirms the previously reported range in female Kuwaitis.26 The reason for this is unclear; the larger amounts of body fat mass, predominantly subcutaneous fat, in women and the effect of sex steroid hormones which increase leptin production have been suggested.18 Since leptin reflects mainly the amount of body fat, this seemes to be a logical explanation for the observed gender dif- ferences. Gender differences and their relationship to body composition were examined in several stud- ies and leptin levels were still found to be significantly higher in women, even after correction was made for BMI or fat mass.19 The current study shows that serum leptin concen- trations were increased in relation to increased body fat content. The positive correlation between body fat and serum leptin is probably explained primarily by the increased release of leptin from large fat cells.19 In fact, some studies have proposed that leptin can serve as an indicator of fat content and that its levels increase exponentially with increasing body fat percentage.3 Leptin levels decrease by reduction of body fat even though BMI values remain unchanged.20 In our study, we found a significant relationship between circulating leptin and BMI, an observation that is associated with the relationship of leptin to to- Figure 2: Correlation between leptin levels (ng/ml) with (A) Fatness (kg) and (B) BMI (kg/m2) in obese Omani patients M A S O U D Y A L - M A S K A R I A N D A D E L A A L N A Q D Y 30 tal body weight as BMI and fatness.2 In all previous in- vestigations, leptin levels have been shown to be high and correlated to BMI.2,3 In agreement with our findings, regarding the exist- ence of a positive correlation between the circulating leptin levels and the body weight, other studies have re- ported the relation of spontaneous or enforced weight changes and serum leptin levels.3 Whatever the initial concentration, weight loss due to food restriction was found to be associated with a decrease in serum leptin in both obese and normal weight humans.2 Based on the above findings, leptin concentrations can be considered as a marker of the extent of obes- ity in human(s). The one relatively common clinical condition, in which a significantly elevated serum lep- tin concentration occurs without an increase in body mass, is chronic renal failure, probably as a result of decreased renal clearance.21 A number of researchers however, have claimed subtle leptin abnormalities in conditions such as diabetes22 and thyroid disease.23 In addition, leptin seems to be involved in the pathogene- sis of some obesity-associated conditions such as ano- vulatory infertility24 and Type 2 diabetes mellitus.25 Although the number of individuals in this study was relatively small, it was found that circulating lep- tin levels were high and positively correlated to body weight, the percentage fat and BMI among obese Om- ani subjects. The pattern of this increase may reflect the differences in lifestyle, diet, physical activity and other cultural and economic factors that are specific for people in this part of the world. The significance of this study in relation to high and increased prevalence of diabetes in Oman requires further evaluation. R E F E R E N C E S 1. Zhang Y, Proenca R, Maffei M, Barone M, Leopald L, Friedman J.M. Positional cloning of mouse ob gene and its human homologue. Nature 1994; 737:425-432. 2. Maffei M, Halaas J, Ravussin E, Pratly R E, Lee G H, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S. Lep- tin levels in human and rodent; measurement of plasma leptin and ob RNA in obese and weight-reduced sub- jects. Nat Med 1995; 1:1155-1161. 3. Considine R V, Sinha M K, Heiman M, Kriauciunas A, Stephens T, Nyce M, Ohannesian J P, Marco C C, Mc- Kee J, Bauer L. Serum immunoreactive-leptin concen- trations in normal-weight and obese humans. N Engl J Med 1996; 334:292-295. 4. Chow VT, Phoon MC. Measurement of serum leptin concentrations in university undergraduates by com- petitive ELISA reveals correlations with body mass in- dex and sex. Adv Physiol Educ 2003; 27:70-77. 5. Trayhurn P, Hoggard N, Mercer J D, Rayner D.V. Leptin: fundamental aspects. Int. J. Obes. Relat Metab Disord 1999; 23:22-28. 6. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin En- docrinol Metab 1996; 81:3419-3443. 7. Janeckova R(a). The role of leptin in human physiology and pathophysiology. Physiol Res 2001; 50:443-459. 8. Janeckova R(b). New findings on the role of leptons in regulation of the reproductive system in humans. Cesk Fysiol 2002; 50:25-30. 9. Chu N, Spiegelman D, Hotamisligil G, Rifai N, Stampfer M, Rimm E. Plasma insulin, leptin and soluble TNF re- ceptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001; 157:495-503. 10. Larmore K, O’Connor D, Sherman T, Funanage V, Has- sink S, Oerter Klein K. Leptin and estradiol as relate to changes in pubertal status and body weight. Med Sci Monit 2002; 8:206-210. 11. Lahlou N, Issa T, Leboue Y, Carel J, Camoin L, Roger M. Leptin might play a role in diabetes. Diabetes 2002; 51: 1980-1985. 12. Asfour M, Lambourne A, Al-Bahlani S, Al-Asfoor D, Bold A, Mahtab H, King H. High prevalence of diabetes mellitus and impaired glucose tolerance in the Sultanate of Oman. Results of the 1991 national survey. Diabet Med 1995; 12:1122-1125. 13. Al-Lawati JA, Al Riyami AM, Mohammed AJ, Jousilahti P. Increasing prevalence of diabetes mellitus in Oman. Diabet Med 2002; 19:954-957. 14. Al-Asfoor DH, Al-Lawati JA, Mohammed AJ. Body fat distribution and the risk of non-insulin-dependant dia- betes mellitus in the Omani population. East Mediterr Health J 1999; 5:14-20. 15. Haluzik M, Kabrt J, Nedvidkora J, Svobodova J, Kotr- likora E, Papezova H. Relationship of serum leptin lev- els and selected nutritional parameters in patients with protein-caloric malnutrition. Nutrition 1999; 15:829- 833. 16. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield S B, Gallagher D, Chew F, Leibel R. Effects of gender, body composition, and menopause on plasma concentra- tions of leptin. J Clin Endocrinol Metab 1996; 81:3424- 3427. 17. Licinio J, Negrao A B, Mantzoros C, Kaklamani V, et al. Sex differences in circulating human leptin pulse ampli- tude: clinical implications. J Clin C Endocrinol Metab 1998; 83:4140-4147. 18. Cassabiell X, Pineiro V, Peino R, et al. Gender differenc- es in both spontaneous and stimulated leptin secretion C O R R E L AT I O N B E T W E E N S E R U M L E P T I N L E V E L S , B O D Y M A S S I N D E X A N D O B E S I T Y I N O M A N I S 31 by human omental adipose tissue in vitro: dexametha- sone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab 1998; 83:2149- 2155. 19. Lonnqvist F, Nordfors L, Jasson M, Thorne A, Shalling M, Arner P. Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expres- sion. J Clin Investig 1997; 99:2398-2404. 20. Stejskal D, Jedelsky L, Ruzicka V, Bartek J. Leptin, in- sulin a proinsulin - vzajemne vztahy. Vnitrini Lekarstvi 1998; 44:361-365. 21. Nordfors L, Lonnqvist F, Heimburger O, Danielsson A, Schalling M, Stenvinkel P. Low leptin gene expression and hyperleptinemia in chronic renal failure. Kidney Int 1998; 54:1267-1275. 22. Rudberg S, Persson B. Serum leptin levels in young females with insulin-dependent diabetes and the rela- tionship to hyperandrogenicity and microalbuminuria. Horm Res 1998; 50:297-302. 23. Valcavi R, Zini M, Peino R, Casaneuva F.F., Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab 1997; 82:1632- 1634. 24. Karlsson C, Lindell K, Svensson E, Bergh C, Lind P, Bil- lig H, Carlsson LM, Carlsson B. Expression of functional leptin receptors in the human ovary. J Clin Endocrinol Metab 1997; 82:4144-4148. 25. Morton N, Emilsson V, de Groot P, Pallett A L, Caw- thorne M. Leptin signalling in pancreatic and clonal insulin-secreting cells. J Mol Endocrinol 1999; 22:173- 184. 26. Kamal A.S. Al-Shoumer, Bagavathy A.K. Vasanthy, Hanan A. Makhlouf, Mona M. Al-Zaid. Leptin levels in Arabs with primary hyperthyroidism. Ann of Saudi Med 2000; 20:113-118.